Antiangiogenic effect of curcumin in pure versus in extract forms

Pharmaceutical Biology

Volumn 46, Issue 10-11, 2008, Pages 677-682

  Liu, Dong ^a   Schwimer, Joshua ^b   Liu, Zhijun ^a   Woltering, Eugene A ^b,c,d,e   Greenway, Frank L ^f  

^a LOUISIANA STATE UNIVERSITY AGRICULTURAL CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Neurosciences Center of Excellence

^e Veterans Administration   (United States)

^f PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Angiogenesis; Curcuma longa; Curcumin; Extract; Solubility; Turmeric

Indexed keywords

ACETONE; ALCOHOL; CURCUMA LONGA EXTRACT; CURCUMIN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CURCUMA LONGA; DRUG SOLUBILITY; HUMAN; HUMAN TISSUE;

CURCUMA LONGA;

EID: 57649179663     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.1080/13880200802215826     Document Type: Article

References (23)

1. Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE, Price JE (2005): Curcumin suppresses the paclitaxel-induced nuclear factor-kb pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 11: 7490-7498.
2. Ammon H, Safayhi H, Mack T, Sabieraj J (1993): Mechanism of antiinflamatory actions of curcumin and boswellic acids. J Ethnopharmacol 38: 105-112.
3. Apisariyakul A, Vanittanakom N, Buddhausukh D (1995): Antifungal activity of turmeric oil extracted from Curcuma longa (Zingiberaceae). J Ethnopharmacol 49: 163-169.
4. Arbiser JL, Klauber N, Rohan R, van Leeuwen R, Huang MT, Fisher C, Flynn E, Byers HR (1998): Curcumin is an in vivo inhibitor of angiogenesis. Mol Med 1: 376-383.
5. Bush JA, Cheung KJJ, Li G (2001): Curcumin induces apoptosis in human melanoma cells through a Fas receptor/Caspase-8 pathway independent of p53. Exp Cell Res 271: 305-314.
6. 2) quencher. Biochem Biophys Res Commum 295: 62-66.
7. Gescher AJ, Sharma RA, Steward WP (2001): Cancer chemoprevention by dietary constituents: A tale of failure and promise. Lancet Oncol 2: 371-379.
8. Hornick C, Myers A, Sadowska-Krowicka H, Anthony C, Woltering E (2003): Inhibition of angiogenic initiation and disruption of newly established human vascular networks by juice of Morinda citrifola (noni). Angiogenesis 6: 143-149.
9. Literat A, Su F, Norwicki M, Durand M, Ramanathan R, Jones CA, Minoo P, Kwong KY (2001): Regulation of pro-inflammatory cytokine expression by curcumin in hyaline membrane disease (HMD). Life Sci 70: 253-267.
10. Liu Z, Schwimer J, Liu D, Greenway FL, Anthony CT, Woltering EA (2005): Black raspberry extract and fractions contain angiogenesis inhibitors. J Agric Food Chem 53: 2909-3915.
11. Lukita-Atmadja W, Ito Y, Baker GL, McCuskey RS (2002): Effect of curcuminoids as anti-inflammatory agents on the hepatic microvascular response to endotoxin. Shock 17: 399-403.
12. Negi PS, Jayaprakasha GK, Jagan Mohan rao L, Sakariah KK (1999): Antibacterial activity of turmeric oil: A byproduct from curcumin manufacture. J Agric Food Chem 47: 4297-4300.
13. Pierce A (1999): The American Pharmaceutical Association Practical Guide to Natural Medicines.. New York, NY, The Stonesong Press, Inc. 638-641.
14. Roth G, Chandra A, Nair M (1998): Novel bioactivities of Curcuma longa constituents. J Nat Prod 61: 542-545.
15. Ruby AJ, Kuttan G, Babu KD, Rajasekharan KN, Kuttan R (1995): Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett 94: 79-83.
16. Shao ZM, Shen ZZ, Liu CH, Sartippour MR, Go VL, Heber D, Nguyen M (2002): Curcumin exerts multiple suppressive effects on human breast carcinoma cells. Int J Cancer 98: 234-240.
17. Srimal RC (1997): Turmeric: A brief review of medicinal properties. Fitoterapia 68: 483-493.
18. Thaloor D, Singh AK, Sidhu GS, Prasad PV, Kleinman HK, Maheshwari RK (1998): Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin. Cell Growth and Differentiation 9: 305-312.
19. Shishodia S, Sethi G, Aggarwal BB (2005): Curcumin: Getting back to the roots. Ann NY Acad Sci 1056: 206-217.
20. Yoysungnoen P, Wirachwong P, Bhattarakosol P, Niimi H, Patumraj S (2005): Antiangiogenic activity of curcumin in hepatocellular carcinoma cells implanted nude mice. Clin Hemorheol Microcirc 33(2): 127-135.
21. Weir NM, Selvendiran K, Kutala VK, Tong L, Vishwanath S, Rajaram M, Tridandapani S, Anant S, Kuppusamy P (2007): Curcumin induces G(2)/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK. Cancer Biol Ther Feb 5; 6(2): 178-184.
22. Woltering EA, Lewis JM, Maxwell PJ IV, Frey DJ, Wang Y-Z, Rothermel J, Anthony CT, Balster DA, O'Leary JP, Harrison LH (2003): Development of a novel in vitro human tissue-based angiogenesis assay to evaluate the effect of antiangiogenic drugs. Ann Surg 237(6): 790-800.
23. Woo HM, Kang JH, Kawada T, Yoo H, Sung MK, Yu R (2007): Active spice-derived components can inhibit inflammatory responses of adipose tissue in obesity by suppressing inflammatory actions of macrophages and release of monocyte chemoattractant protein-1 from adipocytes. Life Sci 80: 926-931.